Clenil Modulite 100mcg may run out of stock
Pharmaceutical giant Chiesi today said its Clenil Modulite 100 microgram pressurised metered dose inhalers are expected to face intermittent supply problems over the next...
Michelle Riddalls is PAGB’s new chief executive
The consumer healthcare association PAGB has appointed Michelle Riddalls as its new chief executive.
Riddalls succeeds John Smith, who has led Proprietary Association of Great...
Nytol highlights connection between sleep and mental health
As the mental health issues receive considerable attention following the priority given in the recently launched NHS Long Term Plan, leading OTC...
India might produce Covid-19 vaccine for the world: Cipla Boss
By Amit Roy
INDIAN businessman Yusuf Hamied believes that a vaccine for coronavirus will be tested on humans in six months, and when it does...
Optel launches FMD compliance solution for pharmacies
Optel, a global technology provider for the pharmaceutical industry, has launched a new transactional website for Optel Certa Software verification and decommissioning...
Officials urged to treat all frontline clinicians equally
By Simon Dukes
Chief Executive
Pharmaceutical Services Negotiating Committee
FOR me, the genuine privilege of being the negotiator for community pharmacy in England is meeting and talking...
Valentine’s Day expected to stimulate ED treatment queries
With Valentine’s Day just around the corner, Pfizer Consumer Healthcare said it expects to see a rise in searches for Viagra Connect.
Boots partners with LIVI to strengthen its digital pharmacy services
Boots UK on Thursday (16) announced a new partnership with digital healthcare provider LIVI to strengthen its digital pharmacy services.
The existing Boots UK and LIVI...
Sanofi reintroduces original formulation Syndol tablets
Sanofi on Wednesday announced the return of original formulation Syndol tablets, which is used for headache and migraine relief, after five years of absence.
The...
Novartis, US drug regulator agree to malaria drug trial to fight Covid-19
Novartis has won the go-ahead from the US Food and Drug Administration to conduct a randomized trial of malaria drug hydroxychloroquine against Covid-19 disease, the...
